9/29/17 9/29/17

Zogenix Announces Positive Top-line Results from Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome

8/8/17 8/8/17

Zynerba’s cannabis-based epilepsy gel fails in phase 2 trial

8/7/17 8/7/17

Compound derived from marijuana interacts with anti-epileptic drugs

7/31/17 7/31/17

Pairnomix, StemoniX Develop Epilepsy Model in Search for New Anti-seizure Drugs

7/30/17 7/30/17

Data Lacking to Explain Why US Doctors Prefer Keppra to Treat Pediatric Epilepsy

6/28/17 6/28/17

Nearly Half of Persons With Epilepsy Forget to Take Their Meds at Least Once a Month, Poll Shows

6/14/17 6/14/17

Epilepsy and natural treatments: Can they help?

5/26/17 5/26/17

In a first, marijuana substance reduces seizures for some epilepsy patients in clinical trial

5/25/17 5/25/17

High School Athlete With Epilepsy Fights to Bring CBD Oil on Campus

5/24/17 5/24/17

Epilepsy Seizure Treatment Trobalt to Be Discontinued in June 2017

5/22/17 5/22/17

USFDA rejects SPARC's epilepsy drug application

5/19/17 5/19/17

University of Warwick research focuses on absence epilepsy that affects children

5/18/17 5/18/17

Protein Found That May Improve Epilepsy Patients’ Response to Therapies

5/16/17 5/16/17

Lawmakers push legislation to provide epilepsy treatment nationwide

5/8/17 5/8/17

Why some images trigger seizures

5/4/17 5/4/17

Members of Congress and Senate in Support of the New CBD Bill

4/25/17 4/25/17

Orphan Drug Designation From the U.S. FDA for EPX-100 and EPX-200 in the Treatment of Patients With Dravet Syndrome

4/20/17 4/20/17

French regulator says up to 4,100 children victims of epilepsy drug